37 results on '"Obara, Wataru"'
Search Results
2. PD38-09 PATHOLOGICAL COMPLETE RESPONSE TO NEOADJUVANT CHEMOTHERAPY IMPROVES ANTITUMOR IMMUNE RESPONSE THROUGH REDUCTION OF REGULATOTY T CELLS IN MUSCLE-INVASIVE BLADDER CANCER
3. PD61-11 INITIAL EXPERIENCE OF ROBOT-ASSISTED RADICAL PROSTATECTOMY USING HINOTORI SURGICAL ROBOT SYSTEM
4. PD16-08 ELUCIDATION OF THE INTERPLAY BETWEEN PHOSPHOLIPID BYOSYNTHESIS AND OXIDATIVE STRESS IN THE PATHOGENESIS OF RENAL CELL CARCINOMA
5. PD41-06 EVALUATION OF THE TUMOR MICROENVIRONMENT OF UPPER TRACT UROTHELIAL CARCINOMA USING MULTIPLEX FLUORESCENCE IMMUNOHISTOCHEMISTRY
6. MP05-19 POLYGENETIC RISK SCORE FOR PROSTATE CANCER IS ASSOCIATED WITH LIPOPOLYSACCHARIDE PATHWAY IN GUT MICROBIOME
7. PD17-05 GENOMIC FEATURES OF RENAL CELL CARCINOMA DEVELOPED DURING END-STAGE RENAL DISEASE AND DIALYSIS
8. PD46-01 DETECTION OF INDIVIDUALIZED MUTATIONS AND MONITORING OF POSTOPERATIVE RECURRENCE USING CIRCULATING TUMOR DNA IN PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA
9. MP38-14 GUT MICROBIOME ASSOCIATED WITH BLOOD TESTOSTERONE LEVELS IN ELDERLY MEN
10. PD58-03 DETECTION OF INDIVIDUALIZED MUTATION USING PLASMA AND URINARY CIRCULATING TUMOR DNA IN PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA
11. MP12-14 SITE-SPECIFIC EARLY RESPONSE PATTERNS IN ADVANCED RCC PATIENTS TREATED WITH NIVOLUMAB AND IPILIMUMAB COMPARED WITH SUNITINIB THERAPY
12. PD40-02 TIM3 EXPRESSION ON TUMOR CELLS PREDICTS RESPONSE TO ANTI-PD-1 THERAPY FOR RENAL CANCER
13. MP14-17 VALIDATION OF REMARCC MODEL FOR SELECTION OF CYTOREDUCTIVE NEPHRECTOMY IN PATIENTS WITH mRCC
14. PD55-04 EFFECT OF NEOADJUVANT CHEMOTHERAPY ON THE IMMUNE MICROENVIRONMENT IN MUSCLE INVASIVE BLADDER CANCER
15. MP15-18 RECONSTRUCTION OF THE RETZIUS SPACE BY PERITONEAL SUTURE FOLLOWING ROBOT-ASSISTED RADICAL PROSTATECTOMY IMPROVES POSTOPERATIVE URINARY INCONTINENCE
16. PD43-03 INDIVIDUALIZED MUTATION DETECTION IN PLASMA AND URINARY CIRCULATING TUMOR DNA FOR MONITORING UPPER TRACT UROTHELIAL CARCINOMA USING DIGITAL POLYMERASE CHAIN REACTION
17. MP31-14 CLINICAL SIGNIFICANCE OF HIGH URINARY SODIUM-TO-POTASSIUM RATIO IN PATIENTS WITH NOCTURNAL POLYURIA
18. MP16-07 MITOCHONDRIAL PROTEIN OF RELEVANT EVOLUTIONARY AND LYMPHOID INTEREST DOMAIN CONTAINING 2 (PRELID2), A NOVEL MOLECULE IN CARCINOGENESIS OF RENAL CELL CARCINOMA
19. PD37-02 HIGHER SALT INTAKE AND NON-DIPPING BLOOD PRESSURE ARE ASSOCIATED WITH NOCTURNAL POLYURIA IN PATIENTS WITH LOWER URINARY TRACT SYMPTOMS
20. MP43-10 INVESTIGATION FOR INTRAVESICAL RECURRENCES BETWEEN WITH AND WITHOUT BCG THERAPIES ACCORDING TO HISTORY OF THERAPEUTIC AGENTS FOR DYSURIA IN NON-MUSCLE INVASIVE BLADDER CANCER
21. MP05-08 ASSOCIATION OF MODIFIED SURGICAL TECHNIQUE FOR PATIENTS WITH SHORTER MEMBRANOUS URETHRAL LENGTH AND EARLY RECOVERY OF INCONTINENCE AFTER ROBOT-ASSISTED LAPAROSCOPIC PROSTATECTOMY
22. MP79-14 NOCTURNAL POLYURIA AND NOCTURNAL BLOOD PRESSURE PATTERNS IN MALE PATIENTS WITH LOWER URINARY TRACT SYMPTOMS
23. MP70-09 IDENTIFICATION OF NINE NEW SUSCEPTIBILITY LOCI FOR PROSTATE CANCER IN THE JAPANESE POPULATION
24. MP49-13 SELECTIVE NEOADJUVANT CHEMOTHERAPY BY PREDICTION SYSTEMS IMPROVES THE CHEMO-SENSITIVITY OF THE MUSCLE INVASIVE BLADDER CANCERS
25. S&T-18 PREOPERATIVE MEMBRANOUS URETHRAL LENGTH BECOMES PREDICT FACTOR FOR THE EARLY URINARY INCONTINENCE AFTER ROBOT ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY
26. MP56-17 ADJUVANT CANCER PEPTIDE VACCINE TREATMENT WITH INTRAVESICAL BCG THERAPY FOR NON-MUSCLE INVASIVE BLADDER CANCER
27. MP49-18 IMPACT OF POLYMORPHISMS IN ABCB1 AND NRI2 WITH DOCETAXEL RESPONSE FOR CASTRATION-RESISTANT PROSTATE CANCER
28. Outcome of Metastasectomy for Urothelial Carcinoma: A Multi-Institutional Retrospective Study in Japan
29. 1439 A PROSPECTIVE STUDY TO EXAMINE THE AVAILABILITY OF THE PREDICTION SYSTEM OF NEOADJUVANT CHEMOTHERAPY FOR MUSCLE INVASIVE BLADDER CANCER
30. 1275 PHASE I CLINICAL TRIAL OF NOVEL CDCA1 DERIVED EPITOPE PEPTIDE VACCINE THERAPY FOR CASTRATION-RESISTANT PROSTATE CANCER
31. 77 PHASE I CLINICAL TRIAL OF NOVEL HIG2 DERIVED EPITOPE PEPTIDE VACCINE TREATMENT FOR KIDNEY CANCER
32. PHASE I CLINICAL TRIAL OF VACCINATION OF MPHOSPH1 AND DEPDC1 EPITOPE PEPTIDE VACCINE FOR PATIENTS WITH BLADDER CANCER
33. Prognostic Significance of Vitamin D Receptor and Retinoid X Receptor Expression in Renal Cell Carcinoma
34. 1099: Development of the Prediction System for Chemosensitivity of Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Neoadjuvant Chemotherapy in Invasive Bladder Cancer Patients
35. 1293: Effect of Combined Treatment of Interferon-A and Vitamin D3 in Advanced Renal Cell Carcinoma
36. 388: Prognostic Significance of Vitamin D Receptor and Retinoid X-Receptors Expression in Renal Cell Carcinoma
37. 368: The Analysis of Vitamin D Receptor and Retinoid X Receptor in Renal Cell Carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.